Use of LetibotulinumtoxinA for Aesthetic Treatment of Asians: A Consensus

Aesthet Surg J. 2023 Oct 13;43(11):NP962-NP974. doi: 10.1093/asj/sjad151.

Abstract

Treatment of wrinkles and dynamic lines with botulinum toxin has been a routine practice for years in aesthetic clinical settings. The effective treatment of wrinkles requires a comprehensive understanding of facial expression muscles and their interactions, the mechanism of action of botulinum toxin, and individual patient preferences. The dose adjustment practice and injection technique of physicians are affected by cultural differences; most Asian patients prefer natural-looking results. This article aims to present an expert consensus on the injection sites, doses, and levels of botulinum toxin for various indications in Asians, with the hope of providing guidance to some clinicians. This consensus paper reviews LetibotulinumtoxinA for patient evaluation, dosage, and delivery techniques in Asians from the time LetibotulinumtoxinA was approved up to December 2022. Panelists proposed individualized treatment plans for botulinum toxin type A (BTxA) treatments in 3 areas-wrinkle removal, contour adjustment, and face lifting-for Asians based on their extensive experience and knowledge of facial anatomy. When using a different BTxA, clinicians should start with a conservative dose and carefully individualize the treatment for each patient, and adjust it according to feedback to obtain a higher satisfaction level.

Publication types

  • Review

MeSH terms

  • Asian People
  • Botulinum Toxins, Type A*
  • Consensus
  • Esthetics
  • Humans
  • Neuromuscular Agents*
  • Skin Aging*

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents